Literature DB >> 28202331

Genetics of gynaecological cancers.

Panayiotis Constantinou1, Marc Tischkowitz2.   

Abstract

Gynaecological cancers accounted for 16.3% of all cancers and 13.9% of all cancer deaths in women globally in 2012. Cancer of the cervix is the most common gynaecological cancer, followed by cancers of the uterus and the ovary. Although cervical cancer is almost exclusively triggered by human papilloma virus infection, approximately 5% of all uterine cancers and 20% of all ovarian cancers are caused by germline mutations in cancer predisposition genes. A number of genetic syndromes are associated with rarer gynaecological tumours. This review focuses on the epidemiology and pathology of inherited gynaecological cancer predisposition syndromes arising because of germline mutations.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  BRCA1; BRCA2; Lynch syndrome; high-throughput DNA sequencing; ovarian cancer; uterine cancer

Mesh:

Year:  2017        PMID: 28202331     DOI: 10.1016/j.bpobgyn.2017.01.004

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  6 in total

Review 1.  Gynaecological cancers and leptin: A focus on the endometrium and ovary.

Authors:  A Ray; J Fornsaglio; S Dogan; S Hedau; D Naik; A De
Journal:  Facts Views Vis Obgyn       Date:  2018-03

2.  Establishment, molecular and biological characterization of HCB-514: a novel human cervical cancer cell line.

Authors:  Marcela Nunes Rosa; Adriane Feijó Evangelista; Letícia Ferro Leal; Cristina Mendes De Oliveira; Viviane Aline Oliveira Silva; Carla Carolina Munari; Fernanda Franco Munari; Graziela De Macêdo Matsushita; Ricardo Dos Reis; Carlos Eduardo Andrade; Cristiano de Pádua Souza; Rui Manuel Reis
Journal:  Sci Rep       Date:  2019-02-13       Impact factor: 4.379

3.  Investigating the causal role of MRE11A p.E506* in breast and ovarian cancer.

Authors:  Islam E Elkholi; Massimo Di Iorio; Somayyeh Fahiminiya; Suzanna L Arcand; HyeRim Han; Clara Nogué; Supriya Behl; Nancy Hamel; Sylvie Giroux; Manon de Ladurantaye; Olga Aleynikova; Walter H Gotlieb; Jean-François Côté; François Rousseau; Patricia N Tonin; Diane Provencher; Anne-Marie MesMasson; Mohammad R Akbari; Barbara Rivera; William D Foulkes
Journal:  Sci Rep       Date:  2021-01-28       Impact factor: 4.379

Review 4.  Rare Hereditary Gynecological Cancer Syndromes.

Authors:  Takafumi Watanabe; Shu Soeda; Yuta Endo; Chikako Okabe; Tetsu Sato; Norihito Kamo; Makiko Ueda; Manabu Kojima; Shigenori Furukawa; Hidekazu Nishigori; Toshifumi Takahashi; Keiya Fujimori
Journal:  Int J Mol Sci       Date:  2022-01-29       Impact factor: 5.923

5.  Evaluation of the Impact of Cisplatin on Variances in the Expression Pattern of Leptin-Related Genes in Endometrial Cancer Cells.

Authors:  Dariusz Dąbruś; Robert Kiełbasiński; Beniamin Oskar Grabarek; Dariusz Boroń
Journal:  Int J Mol Sci       Date:  2020-06-10       Impact factor: 5.923

6.  Association between genetic polymorphisms and endometrial cancer risk: a systematic review.

Authors:  Cemsel Bafligil; Deborah J Thompson; Artitaya Lophatananon; Miriam J Smith; Neil Aj Ryan; Anie Naqvi; D Gareth Evans; Emma J Crosbie
Journal:  J Med Genet       Date:  2020-02-17       Impact factor: 6.318

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.